PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
14-Feb-2024 Atara Biotherapeutics Announces Submission of Investigational New Drug Application for ATA3219 for Treatment of Lupus Nephritis Businesswire
14-Feb-2024 Assent Appoints Ann Klee to Board of Directors Businesswire
14-Feb-2024 Vetter Contributes to Commercial Launches of Eight Customer Products in 2023 Businesswire
14-Feb-2024 ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe Businesswire
14-Feb-2024 Thermo Fisher Scientific Launches New Ion Chromatography Instrument to Improve Reliability, Efficiency, and Functional Adaptability for Labs Businesswire
14-Feb-2024 Rejuvenate Bio Announces Partnership with Leading Animal Health Company to Develop Gene Therapy for Canine Osteoarthritis Businesswire
14-Feb-2024 TheracosBio Extends Partnership with Mark Cuban Cost Plus Drug Company Businesswire
14-Feb-2024 Establishment Labs to Announce Fourth Quarter 2023 Financial Results on February 28 Businesswire
14-Feb-2024 Tesla Continues Reign of Top Shorted Security in January, Finds Hazeltree Shortside Crowdedness Report Businesswire
14-Feb-2024 BlossomHill Therapeutics Chief Executive Officer, Jingrong Jean Cui, Ph.D., Elected to the National Academy of Engineering Businesswire
14-Feb-2024 Cybin Reports Third Quarter Financial Results and Recent Business Highlights Businesswire
14-Feb-2024 JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders Businesswire
14-Feb-2024 United States Ammonia Crackers Industry Research Report 2023-2032 Featuring Key Players - Lindberg/MPH, Gasbarre Products, AMOGY, and Thermal Dynamix - A Judd Service Company - ResearchAndMarkets.com Businesswire
14-Feb-2024 Precision BioSciences Receives Pre-IND Feedback from US FDA for PBGENE-HBV as it Advances Towards Clinical Readiness Businesswire
14-Feb-2024 Antibe Reports Q3 2024 Interim Financial and Operating Results Businesswire
14-Feb-2024 NextPoint Therapeutics Announces Closing of Series B Financing Extension Led by Catalio Capital Management Businesswire
14-Feb-2024 Benson Hill Announces Chief Financial Officer Transition Businesswire
14-Feb-2024 IQVIA Reports Fourth-Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance Businesswire
14-Feb-2024 Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance Businesswire
14-Feb-2024 Satellos to Commence Trading on the Toronto Stock Exchange Businesswire